HLAG Protein (Monomer) (no Peptide)
-
- 抗原 See all HLAG 蛋白
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- 蛋白类型
- Recombinant
- 产品特性
- Monomer
-
宿主
- 人
-
资源
- HEK-293 Cells
- 标记
- This HLAG protein is labelled with no Peptide.
- 原理
- Human HLA-G & B2M Monomer Protein
- 序列
- Gly25-Thr305 (HLA-G) & Ile21-Met119 (B2M)
- 特异性
- Uni-Prot: P17693-1 (HLA-G) , P61769 (B2M)
- 产品特性
- Recombinant Human HLA-G & B2M Monomer Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly25-Thr305(HLA-G) and Ile21-Met119(B2M).
- 纯度
- > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
- 过滤
- 0.22 μm filtered
- 内毒素水平
- Less than 1EU per μg by the LAL method.
- Top Product
- Discover our top product HLAG 蛋白
-
-
- 应用备注
- Can be used for Assess MHC/TCR Binding Affinity, generate custom MHC peptide monomer or tetramer, High Throughput Peptide Screening
- 说明
-
The HLA-G&B2M Monomer is absent from peptide, namely peptide-receptive MHC. It can be loaded with antigenic peptides matching HLA-G. The MHC molecules comprising human HLA alleles and B2M, which can be readily tetramerized and loaded with peptides of choice in a high-throughput manner.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Supplied as 0.22μm filtered solution in PBS ( pH 7.4).
- 储存条件
- -80 °C
- 储存方法
- Valid for 12 months from date of receipt when stored at -80°C.,Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- 别名
- HLA-G (HLAG 产品)
- 别名
- MHC-G Protein, B-F Protein, B-F-S04 Protein, B-F-S05 Protein, B-F-S06 Protein, B-F-S07 Protein, B-FI Protein, B-FIV Protein, BF2 Protein, BFa2 Protein, BFw-03 Protein, BFw-05 Protein, BFz-01 Protein, major histocompatibility complex, class I, G Protein, MHC BF1 class I Protein, HLA-G Protein, BF1 Protein
- 分子量
- 48.40 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Tris-Bis PAGE result.
- 途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-